• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国四川省不同海拔地区新生儿先天性心脏病前瞻性队列研究方案。

Protocol for a prospective cohort study on congenital heart disease in neonates across varied altitudes in Sichuan province, China.

作者信息

Wang Xianmin, Liu Jiaxin, Su Wen, Liu Beibei, Li Lixing, Yan Duo, Wan Weiyi, Luo Tongyong

机构信息

Pediatric Cardiology Center, Sichuan Provincial Women's and Children's Hospital, Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, China.

Department of Population Care, Sichuan Provincial Women's and Children's Hospital, Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, China.

出版信息

PLoS One. 2025 Apr 16;20(4):e0319709. doi: 10.1371/journal.pone.0319709. eCollection 2025.

DOI:10.1371/journal.pone.0319709
PMID:40238778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12002476/
Abstract

Congenital heart disease (CHD) is the most prevalent congenital disorder, contributing significantly to neonate mortality. Despite advances in diagnosis and treatment, the incidence and risk factors of CHD remain underexplored, particularly in regions with varied altitudes. Sichuan Province, China, with its diverse topography and altitudes, provides a unique opportunity to investigate the epidemiology of CHD across different environmental settings. This study aims to explore the incidence, subtypes, and risk factors of CHD in neonates across high, middle, and low-altitude regions of Sichuan Province. It also seeks to assess the effectiveness of the Sichuan Province Newborn CHD Free Screening Project, the impact of CHD on family economics and child development, and to provide data-driven recommendations for improving CHD prevention and control measures. We will conduct a multicenter, prospective cohort study involving neonates with positive CHD screening results and their families, recruited from three cities representing different altitude levels: Aba Tibetan and Qiang Autonomous Prefecture, Mianyang City, and Guangyuan City. Data collection will include birth characteristics, CHD screening outcomes, parental and gestational histories, and blood samples for genetic analysis. The study will monitor treatment outcomes, economic impact, and the growth and development of the children over time. This study will provide critical insights into the epidemiology of CHD in Sichuan Province, particularly in relation to altitude. The results will help optimize CHD screening and management programs, ultimately improving outcomes for affected children and their families.

摘要

先天性心脏病(CHD)是最常见的先天性疾病,是新生儿死亡的重要原因。尽管在诊断和治疗方面取得了进展,但CHD的发病率和危险因素仍未得到充分研究,特别是在海拔高度不同的地区。中国四川省地形和海拔高度多样,为研究不同环境下CHD的流行病学提供了独特的机会。本研究旨在探讨四川省高、中、低海拔地区新生儿CHD的发病率、亚型和危险因素。它还旨在评估四川省新生儿先天性心脏病免费筛查项目的有效性、CHD对家庭经济和儿童发育的影响,并为改进CHD预防和控制措施提供数据驱动的建议。我们将开展一项多中心前瞻性队列研究,研究对象为从代表不同海拔水平的三个城市招募的CHD筛查结果呈阳性的新生儿及其家庭,这三个城市分别是阿坝藏族羌族自治州、绵阳市和广元市。数据收集将包括出生特征、CHD筛查结果、父母和孕期病史,以及用于基因分析的血样。该研究将随时间监测治疗结果、经济影响以及儿童的生长发育情况。本研究将为四川省CHD的流行病学,特别是与海拔高度相关的流行病学提供关键见解。研究结果将有助于优化CHD筛查和管理项目,最终改善患病儿童及其家庭的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/12002476/5bb5ba176927/pone.0319709.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/12002476/5bb5ba176927/pone.0319709.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/12002476/5bb5ba176927/pone.0319709.g001.jpg

相似文献

1
Protocol for a prospective cohort study on congenital heart disease in neonates across varied altitudes in Sichuan province, China.中国四川省不同海拔地区新生儿先天性心脏病前瞻性队列研究方案。
PLoS One. 2025 Apr 16;20(4):e0319709. doi: 10.1371/journal.pone.0319709. eCollection 2025.
2
Newborn screening for congenital heart disease using echocardiography and follow-up at high altitude in China.中国利用超声心动图进行新生儿先天性心脏病筛查及高原地区随访。
Int J Cardiol. 2019 Jan 1;274:106-112. doi: 10.1016/j.ijcard.2018.08.102. Epub 2018 Sep 2.
3
An evaluation of a five-year program for newborn congenital heart disease screening in Jiangsu Province, 2019-2023.2019 - 2023年江苏省新生儿先天性心脏病筛查五年项目评估
BMC Public Health. 2025 Feb 10;25(1):552. doi: 10.1186/s12889-025-21698-4.
4
Cross-sectional study of congenital heart disease among Tibetan children aged from 4 to 18 years at different altitudes in Qinghai Province.青海省不同海拔地区4至18岁藏族儿童先天性心脏病的横断面研究。
Chin Med J (Engl). 2008 Dec 20;121(24):2469-72.
5
[A cross-sectional study of congenital heart disease among children aged from 4 to 18 years at different altitudes in Qinghai province, China].[中国青海省不同海拔地区4至18岁儿童先天性心脏病的横断面研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Dec;30(12):1248-51.
6
Spatial pattern and variations in the prevalence of congenital heart disease in children aged 4-18 years in the Qinghai-Tibetan Plateau.青藏高原 4-18 岁儿童先天性心脏病的流行状况及其空间分布特征。
Sci Total Environ. 2018 Jun 15;627:158-165. doi: 10.1016/j.scitotenv.2018.01.194. Epub 2018 Feb 3.
7
[The prevalence of congenital heart disease in students of Liangshan prefecture in Sichuan province].[四川省凉山州学生先天性心脏病的患病率]
Zhonghua Nei Ke Za Zhi. 2013 Jun;52(6):494-7.
8
A Study on the Prevalence of Osteoporosis in People with Different Altitudes in Sichuan, China.中国四川不同海拔人群骨质疏松症患病率研究。
Clin Interv Aging. 2024 Nov 5;19:1819-1828. doi: 10.2147/CIA.S478020. eCollection 2024.
9
[Study on the epidemiology of congenital heart disease in Tibetan ethnic children aged from 4 to 18 living at different altitudes in Qinghai province].[青海省不同海拔地区4至18岁藏族儿童先天性心脏病流行病学研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Apr;29(4):317-20.
10
Prevalence and composition of CHD at different altitudes in Tibet: a cross-sectional study.西藏不同海拔地区冠心病的患病率及构成:一项横断面研究。
Cardiol Young. 2017 Oct;27(8):1497-1503. doi: 10.1017/S1047951117000567. Epub 2017 Apr 10.

本文引用的文献

1
A new algorithm DEtectS critical Congenital Heart Disease at different altitudes: ANDES-CHD study.一种新算法可在不同海拔检测出严重先天性心脏病:安第斯山脉先天性心脏病(ANDES-CHD)研究
J Perinatol. 2024 Mar;44(3):373-378. doi: 10.1038/s41372-024-01888-5. Epub 2024 Feb 2.
2
[Early detection, diagnosis and treatment principal of congenital heart disease].[先天性心脏病的早期发现、诊断及治疗原则]
Zhonghua Er Ke Za Zhi. 2024 Feb 2;62(2):190-192. doi: 10.3760/cma.j.cn112140-20231031-00337.
3
Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China.
中国先天性心脏病产前及新生儿筛查、诊断和治疗的现状和挑战。
Lancet Child Adolesc Health. 2023 Jul;7(7):479-489. doi: 10.1016/S2352-4642(23)00051-2. Epub 2023 Jun 7.
4
Racial and ethnic disparities in the association of maternal infection during pregnancy and risk of cyanotic congenital heart defects in the United States, 2011-2020.2011 - 2020年美国孕期母体感染与紫绀型先天性心脏病风险关联中的种族和民族差异
Ann Epidemiol. 2023 May;81:1-5. doi: 10.1016/j.annepidem.2023.02.010. Epub 2023 Feb 22.
5
The effect of maternal BMI, smoking and alcohol on congenital heart diseases: a Mendelian randomisation study.母亲 BMI、吸烟和饮酒对先天性心脏病的影响:一项孟德尔随机研究。
BMC Med. 2023 Feb 1;21(1):35. doi: 10.1186/s12916-023-02731-y.
6
The association between folic acid supplementation and congenital heart defects: Systematic review and meta-analysis.叶酸补充与先天性心脏病之间的关联:系统评价与荟萃分析。
SAGE Open Med. 2022 Mar 4;10:20503121221081069. doi: 10.1177/20503121221081069. eCollection 2022.
7
Maternal Periconceptional Folic Acid Supplementation and Risk for Fetal Congenital Heart Defects.母体受孕前叶酸补充与胎儿先天性心脏缺陷风险。
J Pediatr. 2022 Jan;240:72-78. doi: 10.1016/j.jpeds.2021.09.004. Epub 2021 Sep 8.
8
Genomic frontiers in congenital heart disease.基因组学在先天性心脏病中的前沿进展。
Nat Rev Cardiol. 2022 Jan;19(1):26-42. doi: 10.1038/s41569-021-00587-4. Epub 2021 Jul 16.
9
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
10
Prevalence of Congenital Heart Disease Amongst Schoolchildren in Southwest China.中国西南地区学童先天性心脏病患病率。
Indian Pediatr. 2020 Feb 15;57(2):138-141.